The WFNOS 2017 Meeting is CME accredited and EONS approved:

Please click here for the   Online Programme Planner

Use the program planner to search for sessions, abstracts and create your itinerary.

 

 

Thursday, May 4, 2017

WFNOS – EORTC Educational Day

CLINICAL Track
(Room: Kongresssaal)

09:00 – 10:30
Clinical updates

The new WHO classification for clinicians
Andreas von Deimling, Heidelberg/DE

Rare primary brain tumors: how I do it

Primary CNS lymphoma

Khe Hoang-Xuan, Paris/FR

Ependymoma
Mark R. Gilbert, Bethesda/US

10:30 – 11:00Coffee break
11:00 – 12:30
Neurocutaneous syndromes

Von Hippel-Lindau disease
Tracy Todd Batchelor, Boston/US

Neurofibromatosis
Marcos Tatagiba, Tuebingen/DE

Tuberous sclerosis
Daniel Cahill, Boston/US

12:30 – 13:30Lunch break
13:30 – 15:00
Management of gliomas

Report from the jumpstarting brain tumor drug development coalition imaging standardization steering committee
Timothy Cloughesy, Los Angeles/US

Supramaximal resection of low-grade gliomas?
Hugues Duffau, Montpellier/FR

Conservative management of lower-grade gliomas
Warren Mason, Toronto/CAN

15:00 – 15:30Coffee Break
15:30 – 16:30
Research in neuro-oncology

How do I write a scientific paper or a grant proposal?
Deborah Blumenthal, Tel Aviv/ISR

Challenges in the conduct of academic clinical trials: a global view
Roger Stupp, Chicago/US

16:45 - 18:15Industry sponsored symposium (Room Gartensaal)

BASIC SCIENCE Track
(Room: Gartensaal)

09:00 – 10:30
Tumor genetics 2.0

Liquid biopsies
Tom Wurdinger, Amsterdam/NL

Single cell sequencing of gliomas
Mario Suva, Boston/US

Fusion genes in gliomas
Antonio Iavarone, New York/US

10:30 – 11:00Coffee break
11:00 – 12:30
Metabolic abnormalities and therapeutic potential

Glutamine GBM metabolism
Saverio Tardito, Glasgow/UK

Development and properties of a novel pan IDH1 inhibitor
Stephan Pusch, Heidelberg/DE

Exploring metabolic vulnerabilities in IDH mutant gliomas
Simone Niclou, Luxembourg/LU

12:30 – 13:30Lunch break
13:30 – 15:00
Tumor microenvironment

Immunotherapy
Christel Herold-Mende, Heidelberg/DE

Microglia
Bozena Kaminska, Warsaw/PL

Scientific and clinical overview on TTF
Patrick Roth, Zurich/CH

15:00 – 15:30Coffee break
15:30 – 16:30
Tumor biology

Rethinking EGFR
Hui Gan, Melbourne/AU

Tumour evolution
Roel Verhaak, Houston/US

16:45 - 18:15Industry sponsored symposium (Room Kongresssaal)

Friday, May 5, 2017

Nurse Session
(Room: Vortragssaal)

09:00 – 09:10

Welcome and Introduction
Ingela Oberg, Cambridge/UK

09:10 – 09:35

Imaging (radiological presentation)
David Summers, Edinburgh/UK

09:35 – 10:00

Brain metastases management guidelines: Surgery
Philippe Metellus, Marseille/FR

10:00 – 10:30

Challenges in the design and conduct of clinical trials for patients with brain metastases
Michael Weller, Zurich/CH

10:30 – 11:00Coffee break
11:00 – 11:20

The role of the BBB for targeted therapies of brain metastases
Matthias Preusser, Vienna/Austria

11:20 – 11:40

RT treatments for brain metastases (SRS/Gamma knife/Cyber knife)
Fabio Iwamoto, New York/US

11:40 – 12:00

Neoplastic meningitis
Emilie Le Rhun, Lille/FR

12:00 – 12:30

Tolerance of normal brain to treatments
Riccardo Soffietti, Torino/IT

12:30 - 14:00Lunch break / Industry sponsored symposium (Room Kongresssaal)
14:00 – 14:30

Recent developments in the management of brain metastases
Richard Baird, Cambridge/UK

14:30 – 15:15

Evolution of management of brain metastases
Liz Molloy, Manchester/UK

15:15 – 15:30

Closing remarks
Ingela Oberg, Cambridge/UK

15:30 - 17:00WFNOS Meeting: Plenary Session 1 - Brain metastasis: the commonest (Room Kongresssaal)

Friday, May 5, 2017

WFNOS Meeting

08:00 – 09:00

Meet the expert session 1 - Immuno-oncology

(Room Kongresssaal)

iRANO
Hideho Okada, San Francisco/US

Biomarkers for predicting benefit from immuno-therapy
Matthias Preusser, Vienna/AT

Novel side effects and their management
Antonio Omuro, New York/US

 

Meet the Expert Session 2 - Health-related quality of life and other patient-centered outcomes in clinical practice
(Room Gartensaal)

Treatment of eldery glioblastoma patients: quantity of quality of survival?
Martin Taphoorn, The Hague/NL

Cognitive deterioration in patients with brain metastases: due to tumor or to treatment?
Jeffrey S. Wefel, Houston/US

Long-term survivors in neuro-oncology: how do they function?
Rakesh Jalali, Mumbai/IN

 

Meet the Expert Session 3 - Advances in neurosurgery
(Room Kammermusiksaal)

Extent of resection
Mitchel S. Berger, San Francisco/US

Local therapy
Manfred Westphal, Hamburg/DE

Neurosurgical implementation of tumor evolution and heterogeneity in gliobastoma
Do-Hyun Nam, Seoul/KR

09:15 – 10:30
Oral Session 1 - Glioblastoma
(Room Kongresssaal)

From selected abstracts

Oral Session 2 - Pediatric tumors
(Room Gartensaal)

From selected abstracts

Oral Session 3 - Brain metastasis
(Room Kammermusiksaal)

From selected abstracts

10:30 – 11:00Coffee break
11:00 – 12:15
Oral Session 4 - Neurosurgery and neuroimaging
(Room Kongresssaal)

From selected abstracts

Oral Session 5 - Quality of life, palliatiev care and neurotoxicity
(Room Gartensaal)

From selected abstracts

Oral Session 6 - Molecular and cell biology
(Room Kammermusiksaal)

From selected abstracts

12:30-14:00Lunch break / Industry sponsored symposium (Room Kongresssaal)
14:15-14:30
Opening and presidential address
(Room Kongresssaal)
14:30 – 15:15
Keynote lecture 1 - EANO
(Room Kongresssaal)

Current concepts and challenges of trial design in brain and leptomeningeal metastasis
Riccardo Soffietti, Turin/IT

15:30 – 17:00
Plenary Session 1 - Brain metastasis: the commonest primaries
(Room Kongresssaal)

Lung cancer
Rolf Stahel, Zurich/CH

Breast cancer
Manmeet Ahluwalia, Cleveland/US

Malignant melanoma
Mark Rosenthal, Melbourne/AU

 

Plenary Session 2 - Lower grade gliomas
(Room Gartensaal)

Clinical impact of the new WHO classification
Guido Reifenberger, Duesseldorf/DE

Current standards of care
Jan Buckner, Rochester/US

Current trials: a global perspective
Martin van den Bent, Rotterdam/NL

 

Plenary Session 3 - Pediatric brain tumors: current cooperative group trials
(Room Kammermusiksaal)

Europe
Didier Frappaz, Lyon/FR

United States of America
Roger J. Packer, Washington/US

Asia
Ryo Nishikawa, Saitama/JP

17:00 – 18:00Poster Viewing
18:15 – 19:45Industry sponsored symposium
(Room Kongresssaal)

Saturday, May 6, 2017

08:00-09:00
Meet the Expert Session 4 - Symptomatic treatments for brain tumor patients
(Room Kongresssaal)

RANO guideline on steroid use and beyond
Patrick Wen, Boston/US

Epilepsy
Roberta Ruda, Turin/IT

Vascular disorders
James Perry, Toronto/CAN

 

Meet the Expert Session 5 - Neuroimaging across brain tumor entities
(Room Gartensaal)

RANO: an update
Susan Chang, San Francisco/US

New MRI techniques
Martha Nowosielski, Heidelberg/DE

PET
Jörg-Christian Tonn, Munich/DE

 

Meet the Expert Session 6 - Radiation biology & radiotherapy
(Room Kammermusiksaal)

Pharmacological radiosensitization of tumor cells
Erik P. Sulman, Houston/US

Pharmacological radioprotection of nervous tissue
Normand J. Laperriere, Toronto/CAN

High precision, high dose radiotherapy: hype or hope
Do Hoon Lim, Seoul/KR
09:15-10:00
Keynote lecture 2 - ASNO
(Room Kongresssaal)

hTERT in glioma - a multifaceted demigod
Koichi Ichimura, Tokyo/JP

10:00 – 10:30Coffee break
10:30-12:00
Oral Session 7 - Glioblastoma clinical
(Room Kongresssaal)

From selected abstracts

 

Oral Session 8 - Meningiomas, schwannomas and lymphomas
(Room Gartensaal)

From selected abstracts

 

Oral Session 9 - Immunology
(Room Kammermusiksaal)
From selected abstracts
12:15 – 13:15Lunch break / Industry sponsored symposium (Room Kongresssaal)
13:30 – 15:00
Plenary Session 4 – Glioblastoma
(Room Kongresssaal)

IDH as a therapeutic target
Michael Platten, Heidelberg/DE

Vaccination strategies
Michael Weller, Zurich/CH

Viral therapy
John Sampson, Durham/US

 

Plenary Session 5 - Leptomeningeal metastasis
(Room Gartensaal)

Identifying cancers of unknown origin from small samples and liquid biopsies
Pieter Wesseling, Amsterdam/NL

Biomarkers for the diagnosis and treatment of leptomeningeal metastases from solid cancers
Michael Glantz, Hershey/US

Challenges for standardization of diagnosis and treatment of leptomeningeal metastasis: an update on the LANO and EANO/ESMO efforts
Emilie LeRhun, Lille/FR


Plenary Session 6 - Meiningioma
(Room Kammermusiksaal)

Surgery
Gelareh Zadeh, Toronto/CAN

Radiotherapy
Minesh Mehta, Baltimore/US

Systemic therapy
Priscilla Brastianos, Boston/US

15:15 – 16:15Industry sponsored symposium (Room Kongresssaal)
16:30 – 18:00Industry sponsored symposium (Room Kongresssaal)
18:00 – 19:00Poster Viewing

Sunday, May 7, 2017

08:00 - 09:30
 WFNOS session - Presentation by charter societies
(Room Kongresssaal)

Molecular targeted therapy in glioblastoma
Wolfgang Wick, Heidelberg/DE

Local therapy in glioblastoma
E. Antonio Chiocca, Boston/US

Correlation between genetic subgrouping and chemotherapy sensitivity of gliomas
Yuchi Hirose, Toyoake/JP

09:30 - 10:00
EANO General Assembly
(Room Kongresssaal)
10:00 - 11:00
Oral Session 10 - Abstract Highlights
(Room Kongresssaal)

From selected abstracts

11:00 – 11:30Coffee break
11:30-12:30
Oral Session 11 - Gliomas
(Room Kongresssaal)

From selected abstracts

12:30 – 13:15
Keynote lecture 3 - SNO
(Room Kongresssaal)
Immunotherapy: advances and future dircetions
David Reardon, Boston/US
13:15 - 14:00
Awards & Closing remarks
(Room Kongresssaal)

top